Table 1 Demographic statistics on paired cases and controls sequenced herein
|  | Control dose2 vaccinee (n = 149) | dose2 vaccinee (n = 149) | Control dose1 vaccinee (n = 247) | dose1 vaccinee (n = 247) |
|---|---|---|---|---|
Age group | ||||
 0–19 | 2 (1.3) |  | 4 (1.6) | 1 (0.4) |
 20–29 | 20 (13.4) | 5 (3.4) | 31 (12.6) | 31 (12.6) |
 30–39 | 32 (21.5) | 12 (8.1) | 59 (23.9) | 48 (19.4) |
 40–49 | 33 (22.1) | 31 (20.8) | 59 (23.9) | 64 (25.9) |
 50–59 | 22 (14.8) | 24 (16.1) | 55 (22.3) | 53 (21.5) |
 60–69 | 24 (16.1) | 30 (20.1) | 25 (10.1) | 32 (13.0) |
 70–79 | 9 (6.0) | 24 (16.1) | 10 (4.0) | 13 (5.3) |
 80–89 | 7 (4.7) | 22 (14.8) | 4 (1.6) | 5 (2.0) |
 90+ |  | 1 (0.7) |  |  |
Sex | ||||
 Female | 87 (58.4) | 81 (54.4) | 152 (61.5) | 152 (61.5) |
 Male | 62 (41.6) | 68 (45.6) | 95 (38.5) | 95 (38.5) |
District | ||||
 Dan | 25 (16.8) | 23 (15.4) | 22 (8.9) | 22 (8.9) |
 South | 3 (2.0) | 3 (2.0) | 5 (2.0) | 5 (2.0) |
 Haifa | 45 (30.2) | 45 (30.2) | 70 (28.3) | 70 (28.3) |
 Jerusalem | 29 (19.5) | 29 (19.5) | 71 (28.7) | 71 (28.7) |
 Center | 23 (15.4) | 23 (15.4) | 28 (11.3) | 28 (11.3) |
 North | 7 (4.7) | 7 (4.7) | 22 (8.9) | 22 (8.9) |
 Sharon-Shomron | 7 (4.7) | 9 (6.0) | 19 (7.7) | 19 (7.7) |
 Tel Aviv | 10 (6.7) | 10 (6.7) | 10 (4.0) | 10 (4.0) |
Sector | ||||
 General Jewish | 117 (78.5) | 117 (78.5) | 163 (66.0) | 163 (66.0) |
 Jewish Orthodox | 11 (7.4) | 11 (7.4) | 28 (11.3) | 28 (11.3) |
 Non-Jewish | 21 (14.1) | 21 (14.1) | 56 (22.7) | 56 (22.7) |
Vaccine status | ||||
 Non-vaccinated | 149 (100.0) |  | 247 (100.0) |  |
 14–20 days from first dose |  |  |  | 133 (53.8) |
 21–28 days from first dose |  |  |  | 95 (38.5) |
 28+ days from first dose |  |  |  | 19 (7.7) |
 7–13 days from second dose |  | 73 (49.0) |  |  |
 14–20 days from second dose |  | 30 (20.1) |  |  |
 21+ days from second dose |  | 46 (30.9) |  |  |
